AI Article Synopsis
Article Abstract
Background: The most common paradigm in minimally invasive surgery is entry of a single trocar through separate incisions in the abdomen. However, in an effort to decrease postoperative pain and minimize scarring, alternative techniques have been described. Needlescopic surgery uses instruments that are 3 mm or less in diameter. Prior uses of needlescopic instruments have been hindered somewhat by diminished shaft strength and small end-effector size. The Percuvance™ (Teleflex, Wayne, PA) system uses a 2.9-mm shaft with interchangeable 5-mm end effectors in order to minimize abdominal wall trauma while maintaining the functionality of traditional laparoscopic instruments.
Materials And Methods: All patients evaluated for laparoscopic surgery by two surgeons with a foregut and general surgery practice at the Cleveland Clinic (Cleveland, OH) were included in the study. Fifteen consecutive patients were enrolled in the study. Patient demographics and operative results were reviewed.
Results: In March 2015, 15 patients underwent surgery using the Percuvance surgical system at the Cleveland Clinic. There was one conversion to open surgery due to extensive intraabdominal adhesions and unclear anatomy. There was one re-exploration for presumed anastomotic leak, which was negative. Operative time and length of hospital stay were similar to those of standard laparoscopic procedures. There were no deaths in this series. Subjective surgeon experience was overall positive, and functionality of the Percuvance system seemed equal to that of standard 5-mm laparoscopic instrumentation.
Conclusions: This initial experience with the Percuvance system demonstrated effective exchange of 5-mm port sites for needlescopic instruments with similar handling to traditional laparoscopic instruments. This interchangeable system may allow performance similar to standard laparoscopic port instrument orientation and principles in the setting of decreased-caliber access.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/lap.2015.0418 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A microphysiological assay for studying T-cell chemotaxis, trafficking and tumor killing.
Biofabrication
October 2024
Complex In-Vitro Models, GSK, Collegeville, PA, United States of America.
Article Synopsis
- Tumors that do not respond to immunotherapy create barriers that hinder T-cell effectiveness, so improving T-cell movement into these tumors could enhance treatment success.
- Advanced in-vitro models can mimic the complex conditions of tumors, making research findings more applicable to real patient scenarios.
- The study introduced a new scalable microfluidic assay that allows researchers to examine T-cell movement and function in 3D tumor environments, providing insights crucial for developing better cancer immunotherapy strategies.
A piezoresistive-based 3-axial MEMS tactile sensor and integrated surgical forceps for gastrointestinal endoscopic minimally invasive surgery.
Microsyst Nanoeng
September 2024
School of Mechanical and Electrical Engineering, Jiangsu Provincial Key Laboratory of Advanced Robotics, Soochow University, Suzhou, China.
Article Synopsis
- * Researchers propose a microelectromechanical system (MEMS) piezoresistive 3-axial tactile sensor that offers real-time force feedback for surgeons during procedures, with a tiny size of only 3.5 mm in diameter.
- * Experimental results show that the sensor can accurately measure forces up to 1.2 N with a minimal relative error of 1.18%, demonstrating its effectiveness and potential for integration into robotic surgical tools for improving precision in the operating room.
Metformin Restrains the Proliferation of CD4+ T Lymphocytes by Inducing Cell Cycle Arrest in Normo- and Hyperglycemic Conditions.
Biomolecules
July 2024
Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepcion, Concepcion 4070409, Chile.
CD4+ T lymphocytes play a key role in the modulation of the immune response by orchestrating both effector and regulatory functions. The effect of metformin on the immunometabolism of CD4+ T lymphocytes has been scarcely studied, and its impact under high glucose conditions, particularly concerning effector responses and glucose metabolism, remains unknown. This study aims to evaluate the effect of metformin on the modulation of the effector functions and glucose metabolism of CD4+ T lymphocytes under normo- and hyperglycemic conditions.
View Article and Find Full Text PDFClinical efficacy and performance evaluation of a bendable remote robot system for a bone tumour surgery: A pilot animal study.
Int J Med Robot
August 2024
Department of Research, AIRS Inc., 202 Robot Innovation Center, Daegu, South Korea.
Background: Traditional open surgery for bone tumours sometimes has as a consequence an excessive removal of healthy bone tissue because of the limitations of rigid surgical instruments, increasing infection risk and recovery time.
Methods: We propose a remote robot with a 4.5-mm diameter bendable end-effector, offering four degrees of freedom for accessing the inside of the bone and performing tumour debridement.
Chorda Dorsalis System as a Paragon for Soft Medical Robots to Design Echocardiography Probes with a New SOM-Based Steering Control.
Biomimetics (Basel)
March 2024
Centre for Artificial Intelligence and Robotics, Universiti Teknologi Malaysia, Kuala Lumpur 54100, Malaysia.
Continuum robots play the role of end effectors in various surgical robots and endoscopic devices. While soft continuum robots (SCRs) have proven advantages such as safety and compliance, more research and development are required to enhance their capability for specific medical scenarios. This research aims at designing a soft robot, considering the concepts of geometric and kinematic similarities.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!